Skip to main content
Stephan Targan, MD, Infectious Disease, Los Angeles, CA

StephanRTarganMD

Infectious Disease • Los Angeles, CA

Distinguished Professor, Department of Medicine, Cedars Sinai Distinguished Professor, UCLA School of Medicine

Join to view full profile

Dr. Targan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Targan's full profile

Already have an account?

  • Office

    8700 Beverly Blvd
    Los Angeles, CA 90048
    Phone+1 310-423-7723
    Fax+1 310-423-0224

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1976 - 1978
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterFellowship, Infectious Disease, 1975 - 1976
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1971 - 1975
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1972 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Insights into the Genetic Epidemiology of Crohn's and Rare Diseases in the Ashkenazi Jewish Population  
    Stephan Targan, Nir Barzilai, Steven R Brant, Manuel A Rivas, PLoS One

Press Mentions

  • Congrats to Dr. Abreu on Her New IBD Director Position
    Congrats to Dr. Abreu on Her New IBD Director PositionNovember 13th, 2024
  • Cedars-Sinai Taps New Director of F. Widjaja Inflammatory Bowel Disease Institute
    Cedars-Sinai Taps New Director of F. Widjaja Inflammatory Bowel Disease InstituteNovember 11th, 2024
  • Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative Colitis
    Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative ColitisSeptember 26th, 2024
  • Join now to see all

Grant Support

  • IBD: Mucosa Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2012
  • IBD: Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • The Cedars-Sinai Immunobiology Training ProgramNational Institute Of Allergy And Infectious Diseases2010–2011
  • Role Of TL1A In Severity Of Crohn'S Disease InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Inflammatory Bowel Disease Center: Clinical Data Repository - Tissue ProcurementNational Center For Research Resources2007–2010
  • Immunopathology &Aggressive Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Flagellin Reactivity As A Marker For A Subtype Of Crohn'S DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Core--Tissue Procurement &Data Analysis &Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Core ANational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • IBD: Genetics And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Ibd:Tnf-Alpha And Crohn'S Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
  • Immunopathology--Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Flagellin Reactivity As A Marker For A Subtype Of CrohnNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Core--Tissue Procurement /Data Analysis /Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Administration CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Ibd--Mucosa-Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
  • Ibd--Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2004
  • TNF Alpha And Crohns Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
  • IBD Disease Subgroup StratificationNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Core--Tissue Procurement FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Ibd--Immunogenetic Linkage And Subclinical MarkersNational Center For Research Resources1997–2001
  • Ibd--Role Of Activated T-Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
  • Trial Of IV Azathiprine Loading In Subjects With Steroid Refactory Crohn'S DISNational Center For Research Resources1997–1999
  • Ulcerative Colitis Specific Panca--Role In Disease PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • Core--Tissue ProcurementNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1999
  • Ibd--Genetic &Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Activated T Cells And Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Ibd--Genetic 7 Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
  • IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1993
  • Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
  • Ibd--Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992
  • Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991
  • IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1991
  • Mechanism Of The NK Lethal HIT In Programmed Tumor CellsNational Cancer Institute1985–1989
  • Inflammatory Bowel Disease: NK Activity In Gut MucosaNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
  • Inflammatory Bowel Disease: NK Activity In Gut MucosaNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Professional Memberships

Dr. Stephan Targan, Dr. Stephan Targan, MD, Dr. S Targan, Dr. Stephan R Targan